Nuvalent
NUVL
NUVL was delisted on the 14th of July, 2026.
180 hedge funds and large institutions have $4.78B invested in Nuvalent in 2024 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 61 increasing their positions, 62 reducing their positions, and 16 closing their positions.
564% more call options, than puts
Call options by funds: $75.8M | Put options by funds: $11.4M
163% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 16
17% more funds holding
Funds holding: 154 → 180 (+26)
2% more capital invested
Capital invested by funds: $4.7B → $4.78B (+$76.6M)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
2% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 62
3.16% less ownership
Funds ownership: 111.72% → 108.56% (-3.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$110M |
| 2 |
PBA
Paradigm Biocapital Advisors
New York
|
+$25.5M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$25M |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$20.8M |
| 5 |
FAM
Fred Alger Management
New York
|
+$17.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$70M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$33.4M |
| 3 |
Morgan Stanley
New York
|
-$28.8M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$21.1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$19.8M |
NUVL Hedge Fund Activity: Q1 2024 in Review
180 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Nuvalent (NUVL) for Q1 2024, worth a combined $4.78B — up 1.6% from $4.7B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new NUVL positions and 16 closed out — a net gain of 26 holders — while 61 added to existing stakes and 62 trimmed.
The largest buyer was Darwin Global Management, adding an estimated $110M. The largest seller was Bain Capital Life Sciences Investors, cutting an estimated $70M.
- 180 institutional investors held Nuvalent (NUVL) as of Q1 2024, up from 154 in Q4 2023.
- Funds reported $4.78B of Nuvalent stock for Q1 2024, up 1.6% quarter-over-quarter.
- 42 funds opened new Nuvalent positions in Q1 2024 and 16 closed out, a net change of +26 holders.
- The largest Nuvalent buyer in Q1 2024 was Darwin Global Management, an estimated $110M added.
- The largest Nuvalent seller in Q1 2024 was Bain Capital Life Sciences Investors, an estimated $70M sold.
Based on aggregated 13F filings for Q1 2024.